Geode Capital Management
VRXA

Geode Capital Management’s Veraxa Biotech AG VRXA Stock Holding History

Geode Capital Management’s Portfolio VRXA Stock Details VRXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$225K Buy
+119,767
New +$957K ﹤0.01% 3872

Other funds holding VRXA

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 51.47% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Geode Capital Management's VRXA Position: Q2 2026 in Review

Geode Capital Management opened a new position in Veraxa Biotech AG (VRXA) in Q2 2026: 119,767 shares worth $225K. The stake represents ﹤0.01% of the portfolio and ranks #3872 among its holdings.

6 funds tracked by Wall St. Rank hold VRXA as of Q2 2026.

  • Geode Capital Management held 119,767 shares of Veraxa Biotech AG worth $225K as of Q2 2026.
  • Veraxa Biotech AG was a new Geode Capital Management position in Q2 2026.
  • Veraxa Biotech AG made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3872 holding.
  • 6 funds tracked by Wall St. Rank held Veraxa Biotech AG as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.